US approves Novavax COVID jab after delay, adds restrictions

by

US health regulators have given final approval to Novavax’s COVID vaccine after an unusual delay and have placed new restrictions on the jab, the pharmaceutical company announced Monday.

Leave A Comment

Your email address will not be published. Required fields are marked *